APA (7th ed.) Citation

M, F., & K, K. (2018). Editorial: Monitoring vedolizumab trough serum concentration in inflammatory bowel disease-following the fate of anti-TNF-alpha agents? Alimentary pharmacology & therapeutics, 47(9), 1323. https://doi.org/10.1111/apt.14588

Chicago Style (17th ed.) Citation

M, Fragaki, and Karmiris K. "Editorial: Monitoring Vedolizumab Trough Serum Concentration in Inflammatory Bowel Disease-following the Fate of Anti-TNF-alpha Agents?" Alimentary Pharmacology & Therapeutics 47, no. 9 (2018): 1323. https://doi.org/10.1111/apt.14588.

MLA (9th ed.) Citation

M, Fragaki, and Karmiris K. "Editorial: Monitoring Vedolizumab Trough Serum Concentration in Inflammatory Bowel Disease-following the Fate of Anti-TNF-alpha Agents?" Alimentary Pharmacology & Therapeutics, vol. 47, no. 9, 2018, p. 1323, https://doi.org/10.1111/apt.14588.